<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00120744</url>
  </required_header>
  <id_info>
    <org_study_id>2003-12038</org_study_id>
    <nct_id>NCT00120744</nct_id>
  </id_info>
  <brief_title>Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Gastroenteritis in a Pediatric Emergency Department</brief_title>
  <official_title>Randomized Trial of the Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Acute Gastroenteritis in a Pediatric Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ann &amp; Robert H Lurie Children's Hospital of Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Hospital for Sick Children</source>
  <brief_summary>
    <textblock>
      The objectives of the study were to determine whether ondansetron treatment would reduce:&#xD;
&#xD;
        -  the amount of vomiting in the emergency department;&#xD;
&#xD;
        -  the need for intravenous rehydration; and&#xD;
&#xD;
        -  the need for hospitalization.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:&#xD;
&#xD;
      Vomiting may limit the success of oral rehydration in children with gastroenteritis and&#xD;
      dehydration. Limited data suggest that while oral ondansetron may reduce vomiting from&#xD;
      gastroenteritis, emergency department revisits may increase.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      The investigators conducted a prospective, double-blind randomized trial at a pediatric&#xD;
      emergency department in 214 dehydrated children, aged 6 months to 10 years with&#xD;
      gastroenteritis and mild to moderate dehydration as assessed by a dehydration score. They&#xD;
      were randomly assigned to receive treatment with an ondansetron oral disintegrating tablet or&#xD;
      placebo. Oral rehydration was administered according to a standard protocol. The primary&#xD;
      outcome was the proportion of children who vomited during oral rehydration therapy. The&#xD;
      secondary outcomes were the mean number of episodes of vomiting, and the proportion of&#xD;
      children treated with intravenous rehydration or hospitalized.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2004</start_date>
  <completion_date type="Actual">April 2005</completion_date>
  <primary_completion_date type="Actual">April 2005</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The proportion of children who vomit during oral rehydration therapy after receiving either 0.13-0.27 mg per kilogram of an oral disintegrating ondansetron tablet or placebo.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>To compare in each treatment arm: mean number of episodes of vomiting, the proportion of children administered supplemental intravenous rehydration or requiring hospitalization.</measure>
  </secondary_outcome>
  <condition>Gastroenteritis</condition>
  <condition>Vomiting</condition>
  <condition>Diarrhea</condition>
  <condition>Dehydration</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ondansetron Oral Disintegrating Tablet</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Acute gastroenteritis&#xD;
&#xD;
          -  Non-bilious and non-bloody vomiting within 4 hours of triage&#xD;
&#xD;
          -  Diarrhea&#xD;
&#xD;
          -  Mild to moderate dehydration&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Weight less than 8 kilograms&#xD;
&#xD;
          -  Severe dehydration&#xD;
&#xD;
          -  Underlying disease which might affect the assessment of hydration status (e.g.,&#xD;
             chronic renal failure, hypoalbuminemia, congestive heart failure, on diuretics)&#xD;
&#xD;
          -  History of abdominal surgery&#xD;
&#xD;
          -  Hypersensitivity to the drug or any components in its formulation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen B Freedman, MDCM, MSCI</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hospital for Sick Children</affiliation>
  </overall_official>
  <link>
    <url>http://www.nejm.org/doi/full/10.1056/NEJMoa055119</url>
    <description>Publication</description>
  </link>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>July 12, 2005</study_first_submitted>
  <study_first_submitted_qc>July 18, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2005</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hospital for Sick Children</investigator_affiliation>
    <investigator_full_name>Stephen Freedman</investigator_full_name>
    <investigator_title>Adjunct Scientist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroenteritis</mesh_term>
    <mesh_term>Dehydration</mesh_term>
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ondansetron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

